A novel acquired EGFR-SEPT14 fusion confers differential drug resistance to EGFR inhibitors in lung adenocarcinoma
Autores principales: | , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Chongqing Medical University
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10404941/ https://www.ncbi.nlm.nih.gov/pubmed/37554188 http://dx.doi.org/10.1016/j.gendis.2023.02.019 |
_version_ | 1785085410645377024 |
---|---|
author | Wang, Weidong Lv, Wang Wang, Hui Xu, Yang Yan, Junrong Shen, Han-Ming Shan, Liqun Hu, Jian |
author_facet | Wang, Weidong Lv, Wang Wang, Hui Xu, Yang Yan, Junrong Shen, Han-Ming Shan, Liqun Hu, Jian |
author_sort | Wang, Weidong |
collection | PubMed |
description | |
format | Online Article Text |
id | pubmed-10404941 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2023 |
publisher | Chongqing Medical University |
record_format | MEDLINE/PubMed |
spelling | pubmed-104049412023-08-08 A novel acquired EGFR-SEPT14 fusion confers differential drug resistance to EGFR inhibitors in lung adenocarcinoma Wang, Weidong Lv, Wang Wang, Hui Xu, Yang Yan, Junrong Shen, Han-Ming Shan, Liqun Hu, Jian Genes Dis Rapid Communication Chongqing Medical University 2023-04-24 /pmc/articles/PMC10404941/ /pubmed/37554188 http://dx.doi.org/10.1016/j.gendis.2023.02.019 Text en © 2023 The Authors. Publishing services by Elsevier B.V. on behalf of KeAi Communications Co., Ltd. https://creativecommons.org/licenses/by/4.0/This is an open access article under the CC BY license (http://creativecommons.org/licenses/by/4.0/). |
spellingShingle | Rapid Communication Wang, Weidong Lv, Wang Wang, Hui Xu, Yang Yan, Junrong Shen, Han-Ming Shan, Liqun Hu, Jian A novel acquired EGFR-SEPT14 fusion confers differential drug resistance to EGFR inhibitors in lung adenocarcinoma |
title | A novel acquired EGFR-SEPT14 fusion confers differential drug resistance to EGFR inhibitors in lung adenocarcinoma |
title_full | A novel acquired EGFR-SEPT14 fusion confers differential drug resistance to EGFR inhibitors in lung adenocarcinoma |
title_fullStr | A novel acquired EGFR-SEPT14 fusion confers differential drug resistance to EGFR inhibitors in lung adenocarcinoma |
title_full_unstemmed | A novel acquired EGFR-SEPT14 fusion confers differential drug resistance to EGFR inhibitors in lung adenocarcinoma |
title_short | A novel acquired EGFR-SEPT14 fusion confers differential drug resistance to EGFR inhibitors in lung adenocarcinoma |
title_sort | novel acquired egfr-sept14 fusion confers differential drug resistance to egfr inhibitors in lung adenocarcinoma |
topic | Rapid Communication |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10404941/ https://www.ncbi.nlm.nih.gov/pubmed/37554188 http://dx.doi.org/10.1016/j.gendis.2023.02.019 |
work_keys_str_mv | AT wangweidong anovelacquiredegfrsept14fusionconfersdifferentialdrugresistancetoegfrinhibitorsinlungadenocarcinoma AT lvwang anovelacquiredegfrsept14fusionconfersdifferentialdrugresistancetoegfrinhibitorsinlungadenocarcinoma AT wanghui anovelacquiredegfrsept14fusionconfersdifferentialdrugresistancetoegfrinhibitorsinlungadenocarcinoma AT xuyang anovelacquiredegfrsept14fusionconfersdifferentialdrugresistancetoegfrinhibitorsinlungadenocarcinoma AT yanjunrong anovelacquiredegfrsept14fusionconfersdifferentialdrugresistancetoegfrinhibitorsinlungadenocarcinoma AT shenhanming anovelacquiredegfrsept14fusionconfersdifferentialdrugresistancetoegfrinhibitorsinlungadenocarcinoma AT shanliqun anovelacquiredegfrsept14fusionconfersdifferentialdrugresistancetoegfrinhibitorsinlungadenocarcinoma AT hujian anovelacquiredegfrsept14fusionconfersdifferentialdrugresistancetoegfrinhibitorsinlungadenocarcinoma AT wangweidong novelacquiredegfrsept14fusionconfersdifferentialdrugresistancetoegfrinhibitorsinlungadenocarcinoma AT lvwang novelacquiredegfrsept14fusionconfersdifferentialdrugresistancetoegfrinhibitorsinlungadenocarcinoma AT wanghui novelacquiredegfrsept14fusionconfersdifferentialdrugresistancetoegfrinhibitorsinlungadenocarcinoma AT xuyang novelacquiredegfrsept14fusionconfersdifferentialdrugresistancetoegfrinhibitorsinlungadenocarcinoma AT yanjunrong novelacquiredegfrsept14fusionconfersdifferentialdrugresistancetoegfrinhibitorsinlungadenocarcinoma AT shenhanming novelacquiredegfrsept14fusionconfersdifferentialdrugresistancetoegfrinhibitorsinlungadenocarcinoma AT shanliqun novelacquiredegfrsept14fusionconfersdifferentialdrugresistancetoegfrinhibitorsinlungadenocarcinoma AT hujian novelacquiredegfrsept14fusionconfersdifferentialdrugresistancetoegfrinhibitorsinlungadenocarcinoma |